quinazolines has been researched along with s,n,n'-tripropylthiocarbamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fredholm, BB; Johansson, B; Kuzmin, A; Zvartau, EE | 1 |
| DeMartini, K; Dunlap, A; Gallagher, A; Krystal, JH; O'Malley, SS; Patel, KT; Pearlson, GD; Potenza, MN; Stevens, MC | 1 |
1 trial(s) available for quinazolines and s,n,n'-tripropylthiocarbamate
| Article | Year |
|---|---|
Effects of the Fyn kinase inhibitor saracatinib on ventral striatal activity during performance of an fMRI monetary incentive delay task in individuals family history positive or negative for alcohol use disorder. A pilot randomised trial.
Topics: Alcohol Drinking; Alcoholism; Benzodioxoles; Humans; Magnetic Resonance Imaging; Motivation; Pilot Projects; Quinazolines; Reward | 2022 |
1 other study(ies) available for quinazolines and s,n,n'-tripropylthiocarbamate
| Article | Year |
|---|---|
Caffeine, acting on adenosine A(1) receptors, prevents the extinction of cocaine-seeking behavior in mice.
Topics: Animals; Behavior, Animal; Caffeine; Cocaine; Extinction, Psychological; Male; Mice; Mice, Inbred DBA; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Reward; Substance Abuse, Intravenous; Theophylline; Triazoles; Xanthines | 1999 |